anidulafungin cost effective despite high acquisition costs

PharmacoEconomics & Outcomes News 632 - 9 Jul 2011 Anidulafungin cost effective despite high acquisition costs According to researchers from Australia, anidulafungin is cost effective for the treatment of invasive candidiasis. The researchers used a decision analytic model to compare the cost effectiveness of anidulafungin versus fluconazole from an Australian hospital perspective. While anidulafungin was substantially more expensive in terms of acquisition costs ($A695.00 vs $7.20 per vial) and, as a result, more expensive in terms of total costs per successfully treated patient ($74 587 vs $60 945), it was associated with a lower mortality rate in clinical trials. Anidulafungin was estimated to save an average of 0.53 additional life-years versus fluconazole. Anidulafungin was therefore associated with an incremental cost-effectiveness ratio (ICER) of $25 740 per life-year saved, which, the researchers suggest, is "below the implicit ICER threshold for Australia". They conclude that, this finding emphasizes that the traditional cost-containment concept, which is primarily based on superficial cost considerations, in particular drug acquisition costs, should not be the sole determinant in the choice of antifungal agent." Neoh CF, et al. Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis. Journal of Antimicrobial Chemotherapy : 30 May 2011. Available from: URL: http://dx.doi.org/10.1093/jac/dkr186 803056664 1 PharmacoEconomics & Outcomes News 9 Jul 2011 No. 632 1173-5503/10/0632-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved

Upload: lyanh

Post on 17-Mar-2017

215 views

Category:

Documents

3 download

Report

Download

Embed Size (px):

TRANSCRIPT

PharmacoEconomics & Outcomes News 632 - 9 Jul 2011

Anidulafungin cost effectivedespite high acquisition costs

According to researchers from Australia,anidulafungin is cost effective for the treatment ofinvasive candidiasis.

The researchers used a decision analytic model tocompare the cost effectiveness of anidulafungin versusfluconazole from an Australian hospital perspective.While anidulafungin was substantially more expensivein terms of acquisition costs ($A695.00 vs $7.20 pervial) and, as a result, more expensive in terms of totalcosts per successfully treated patient ($74 587 vs$60 945), it was associated with a lower mortality rate inclinical trials. Anidulafungin was estimated to save anaverage of 0.53 additional life-years versus fluconazole.Anidulafungin was therefore associated with anincremental cost-effectiveness ratio (ICER) of $25 740per life-year saved, which, the researchers suggest, is"below the implicit ICER threshold for Australia". Theyconclude that, this finding emphasizes that thetraditional cost-containment concept, which is primarilybased on superficial cost considerations, in particulardrug acquisition costs, should not be the soledeterminant in the choice of antifungal agent."Neoh CF, et al. Cost-effectiveness analysis of anidulafungin versus fluconazole forthe treatment of invasive candidiasis. Journal of Antimicrobial Chemotherapy : 30May 2011. Available from: URL: http://dx.doi.org/10.1093/jac/dkr186 803056664

Final Package Insert for ERAXIS (anidulafungin) for Injection

Acquisition of semantics CAS LX 500 A1 Language Acquisition · CAS LX 500 A1 Language Acquisition Week 14a. Acquisition of semantics Acquisition of semantics •Relatively recently,

2015 Third Quarter Results - BBVA...despite geopolitical risk Footprint In spite of slowdown, 2-3% GDP growth rate is expected October th30 2015 2015 Third Quarter Results 4 Acquisition

Survey of Teacher Literacy Knowledge and Efficacy · teachers’ knowledge of phonology, orthography, morphology, literacy-acquisition, and instruction was high. Despite the growing

Office of Acquisition & Project Management ACQUISITION

Final Package Insert for ERAXIS (anidulafungin) for Injection021948s000lbl.pdffunction. Anidulafungin is not dialyzable and may be administered without regard to the timing of hemodialysis

Conviction despite Uncertainties

Acquisition Guide · 2016-04-01 · Acquisition Guide

Dual Link · 2019-07-02 · Dual Link Film still continues to dominate within high-end production as the main acquisition medium, despite all the advances in digital signal processing

DESPITE IT ALL!

· Web viewYes. Provide details: Click or tap here to enter text. No. Explain the rationale for the proposed acquisition despite the proposed controller(s) not having a corporate

Cooperative Mergers and Acquisitions: The Role of Capital ...Cooperative Mergers and Acquisitions Despite the depth of both empirical and qualitative studies on merger and acquisition